Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.09.2016 | Case report

Capecitabine/cisplatin

Sudden death and non-neutropenic pneumonia: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Ciltas A, et al. Efficacy and toxicity of cisplatin and capecitabine combination in the first-line treatment of patients with advanced gastric cancer: A multicenter study by the anatolian society of medical oncology. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi 26: 96-102, No. 2, Jan 2016. Available from: URL: http://www.uhod.org/pdf/PDF_702.pdf - Turkey Ciltas A, et al. Efficacy and toxicity of cisplatin and capecitabine combination in the first-line treatment of patients with advanced gastric cancer: A multicenter study by the anatolian society of medical oncology. UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi 26: 96-102, No. 2, Jan 2016. Available from: URL: http://​www.​uhod.​org/​pdf/​PDF_​702.​pdf - Turkey
Metadaten
Titel
Capecitabine/cisplatin
Sudden death and non-neutropenic pneumonia: 2 case reports
Publikationsdatum
01.09.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-20830-2

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Metronidazole

Case report

Iodixanol

Case report

Diphencyprone

Case report

Thiamazole